RxDoctor Payments DataLook up a doctor →

Betty Mays

Family · Mooresville, NCNPI 1881913382

Payments from drug & device makers

$15,042in general payments, 2019–2025

Across 848 payments — averaging $17.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Teva Pharmaceuticals USA, Inc.$825
  • Neurelis, Inc.$795
  • Novartis$760
  • Lundbeck LLC$614
  • Eisai Inc.$587
  • plus $10K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie91$1,407
Teva Pharmaceuticals USA, Inc.65$825
Neurelis, Inc.35$795
Novartis54$760
Lundbeck LLC21$614
Eisai Inc.33$587
Pfizer34$543
UCB, Inc.30$543
Sumitomo Pharma America, Inc.24$526
Collegium Pharmaceutical, Inc.24$500
SK Life Science, Inc.24$414
Biohaven Pharmaceuticals, Inc.25$374
Sunovion Pharmaceuticals Inc.21$361
Indivior Inc.13$357
Takeda Pharmaceuticals U.S.A., Inc.18$346
Neurocrine Biosciences, Inc.15$314
Biohaven Pharmaceutical Holding Company Ltd.21$291
Lilly USA, LLC16$277
Biogen16$247
Upsher-smith Laboratories LLC14$238
MDD US Operations, LLC18$229
Bristol Myers Squibb12$227
Supernus Pharmaceuticals, Inc.24$197
Avanir Pharmaceuticals, Inc.11$188
Acadia Pharmaceuticals Inc10$182
Jazz Pharmaceuticals Inc.9$179
Johnson & Johnson9$176
Virtus Pharmaceuticals LLC8$175
Scilex Pharmaceuticals Inc.8$173
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC7$165
Arbor Pharmaceuticals, Inc.8$161
Forte Bio-pharma LLC7$161
Aquestive Therapeutics, Inc.8$153
Amgen5$143
GRT US Holding, Inc.10$130
Sanofi4$107
Corium, LLC5$106
Vertex4$99
E.r. Squibb & Sons, L.L.C.4$90
Mallinckrodt Hospital Products Inc.4$88
Banner Life Sciences, LLC4$85
Almatica Pharma LLC4$82
Insightec,inc2$80
Valinor Pharma, LLC4$80
Merck5$73
Medtronic3$72
EMD Serono, Inc.4$71
AstraZeneca(2 entities)4$68
Livanova USA, Inc.3$63
Abbott3$62
Novo Nordisk3$59
Ultragenyx Pharmaceutical Inc.3$58
Tonix Medicines, Inc.2$51
Avadel CNS Pharmaceuticals, LLC2$48
Acorda Therapeutics, Inc2$47
Boston Scientific2$46
Argenx US, Inc.2$44
GE HealthCare2$44
PTC Therapeutics, Inc.2$39
Avion Pharmaceuticals2$39

How this compares

$15,042 in reported general payments places this provider in the 95th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Medicare billing

Part B allowed, 2024
$58,907
Medicare patients
110
Services billed
620

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Mooresville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →